ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2021
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05043168 (Kidney Histopathological Features in Patients After COVID-19 and SARS-CoV-2 Vaccination), which is not on this map. Cited by 67 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Kidney Histopathological Features in Patients After COVID-19 and SARS-CoV-2 Vaccination
Who cites it
67 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review.Frontiers in medicine · 2025Pooled it
- Nephrotic syndrome following COVID-19 vaccination: a systematic review.Journal of nephrology · 2023Pooled it
- COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area.Pediatric nephrology (Berlin, Germany) · 2022Pooled it
- Long COVID and the kidney.Nature reviews. Nephrology · 2025Review
- Gross hematuria after COVID-19 mRNA vaccination and kidney function trajectory in IgA nephropathy.Scientific reports · 2025Article
- A scoping review on adult patients with de novo glomerular diseases following COVID-19 infection or vaccine.International urology and nephrology · 2025Article
- Adverse reactions and effects on renal function of COVID-19 vaccines in patients with IgA nephropathy.Clinical and experimental nephrology · 2024Article
- APOL1 High-Risk Genotype is Not Associated With New or Worsening of Proteinuria or Kidney Function Decline Following COVID-19 Vaccination.Kidney international reports · 2024Article
- De Novo Biopsy-Proven Glomerular Disease Following COVID-19 Vaccination.Journal of clinical medicine · 2024Article
- The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy.Clinical kidney journal · 2024Article
- Kidney Dysfunction and Pathology in the Setting of Hemophagocytic Lymphohistiocytosis.Kidney international reports · 2024Article
- Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review.Vaccines · 2024Article
- Clinical considerations and practical issues of kidney complications in children after COVID-19 infection or vaccination.Clinical and experimental pediatrics · 2024Article
- Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024Observational
- Safety and effectiveness of COVID-19 vaccines in patients with IgA nephropathy: a retrospective cohort study from the TriNetX global collaborative networks.EClinicalMedicine · 2023Article
- Vaccines and nephrotic syndrome: efficacy and safety.Pediatric nephrology (Berlin, Germany) · 2023Review
- Hilar lymphadenopathy, development of tubulointerstitial nephritis, and dense deposit disease following Pfizer-BioNTech COVID-19 vaccination.CEN case reports · 2023Article
- Article
- Clinicopathological and immunological features of new onset kidney disease: a rare event after SARS-CoV-2 vaccination.National science review · 2023Article
- Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report.BMC nephrology · 2023Article
7 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.